Chemical Structure : BPR2-D2
Catalog No.: PC-24923Not For Human Use, Lab Use Only.
BPR2-D2 is a small molecule inhibitor against influenza virus with excellent antiviral efficacy for the oseltamivir-resistant virus (EC50= 0.021 to 0.040 uM), may target viral ribonucleoproteins (RNPs) for viral RNA synthesis, also inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with IC50 of 4.6 uM.
Bulk size, bulk discount!
Welcome credit card payment!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BPR2-D2 is a small molecule inhibitor against influenza virus with excellent antiviral efficacy for the oseltamivir-resistant virus (EC50= 0.021 to 0.040 uM), may target viral ribonucleoproteins (RNPs) for viral RNA synthesis, also inhibits SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) with IC50 of 4.6 uM.
BPR2-D2 inhibits 100% of the virus-induced CPE at a concentration of 0.05 µM.
BPR2-D2 also exhibits a broad antiviral spectrum against various strains of influenza A and influenza B viruses.
BPR2-D2 has previously shown notable anti-influenza activity and broad-spectrum inhibitory effects against RNA viruses.
BPR2-D2 effectively inhibits SARS-CoV-2 by modulating its RdRp function.
M.Wt | 380.40 | |
Formula | C25H16O4 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. Shih SR, et al. J Antimicrob Chemother. 2010 Jan;65(1):63-71.
2. Tang WF, et al. Biomed Pharmacother. 2025 Jun 20;189:118252.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright